Updated April 2021 8%. That is the five-year survival rate for someone diagnosed with pancreatic cancer in Canada. This disease waits for no one, so neither do we – even amidst a global pandemic. For over 40 years there has been a “one size fits...
Today I am thrilled to announce the launch of our next landmark research investment, PASS-01: a clinical trial that will finally address the diverse nature of this disease and provide personalized treatment options for advanced pancreatic cancer patients....
New Clinical Trial Studies Pancreatic Cancer Tumor Traits to Uncover Better Treatment Options NEW YORK – March 30, 2021 – A new team of pioneering pancreatic cancer researchers has been formed to predict which treatments might work best for...
What you Need to Know About Wills in 40 Minutes On Demand Webinar With so much to consider, we know creating or updating your will can be a daunting task. That’s why we asked Certified Executor Advisor Walter Viner to share some important advice with our...
Canadian Oncology Community Unites For World Cancer Day: Shedding Light on the Impact of Covid-19 on Cancer Care Oncologists estimate cancer diagnoses down 25 per cent in some areas as a result of COVID-19 Some oncologists are also reporting an increase in later...
Recent Comments